APA (7th ed.) Citation

A, P., E, B., A, B., L, B., C, C., V, C., . . . G, E. (2025). Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: A multicenter retrospective real-world observational study. European journal of internal medicine, 138, 91. https://doi.org/10.1016/j.ejim.2025.05.016

Chicago Style (17th ed.) Citation

A, Palermo, et al. "Recombinant Human Hyaluronidase-facilitated Subcutaneous Immunoglobulin (hf-SCIg) for Inflammatory Myositis: A Multicenter Retrospective Real-world Observational Study." European Journal of Internal Medicine 138 (2025): 91. https://doi.org/10.1016/j.ejim.2025.05.016.

MLA (9th ed.) Citation

A, Palermo, et al. "Recombinant Human Hyaluronidase-facilitated Subcutaneous Immunoglobulin (hf-SCIg) for Inflammatory Myositis: A Multicenter Retrospective Real-world Observational Study." European Journal of Internal Medicine, vol. 138, 2025, p. 91, https://doi.org/10.1016/j.ejim.2025.05.016.